DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
05/04/2023* 16:30 EST Earnings Call Q1 2023 -- -- --
05/04/2023* -- Results Q1 2023 -- -0.07 --
03/08/2023 16:30 EST Earnings Call Q4 2022 -- -- --
03/08/2023 -- Results Q4 2022 0.25 0.24 3.55%
11/08/2022 16:30 EST Earnings Call Q3 2022 -- -- --
11/08/2022 -- Results Q3 2022 0.07 0.04 88.48%
08/09/2022 16:30 EST Earnings Call Q2 2022 -- -- --
08/09/2022 -- Results Q2 2022 0.04 0.09 -55.56%
*Estimated Date/Time

Earnings

Next Report Date 05/04/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 03/08/2023
Beat/Miss Upgrade
Return Since -9.85%
Last FQE 12/31/2022
Next FQE 03/31/2023

Profile

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
URL https://www.optimizerx.com
Investor Relations URL https://investors.optimizerx.com/
HQ State/Province Michigan
Sector Healthcare
Industry Health Information Services
Equity Style Small Cap/Growth
Next Earnings Release May. 04, 2023 (est.)
Last Earnings Release Mar. 08, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
-33.61%
93.83%
132.9%
-6.38%
203.4%
99.33%
-72.95%
-12.86%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
7.50%
-41.37%
-88.36%
-23.53%
-10.26%
155.7%
25.98%
-26.39%
2.71%
8.42%
23.65%
122.2%
42.53%
75.73%
-44.81%
-48.39%
-11.96%
50.56%
-0.71%
95.06%
43.22%
20.44%
-20.14%
6.40%
7.22%
-40.57%
179.8%
22.68%
4.48%
4.83%
81.84%
5.80%
5.48%
As of March 31, 2023.

Profile

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
URL https://www.optimizerx.com
Investor Relations URL https://investors.optimizerx.com/
HQ State/Province Michigan
Sector Healthcare
Industry Health Information Services
Equity Style Small Cap/Growth
Next Earnings Release May. 04, 2023 (est.)
Last Earnings Release Mar. 08, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
JAMIX 2.975M USD 6.15%
JSCGX 445788.0 USD 5.86%
JFWD 139557.0 USD 4.65%
JMIGX 1.036M USD 3.87%
PDFDX 252000.0 USD 3.26%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter OPRX Tweets